Comparison of the efficacy of nebulized budesonide and systemic steroids in children admitted to the emergency service with acute asthma attacks

Aim: Systemic steroids are used when necessary in the treatment of acute asthma attacks, but they have a high potential for side effects. The role of nebulized steroids in acute asthma attacks is controversial and there are few studies on the subject. In our study, it was aimed to evaluate the efficacy of nebulized budesonide treatment in children presenting with acute asthma attack. Materials and Methods: In this study, patients aged 5-18 years who presented to emergency service with a mild acute asthma attack were evaluated. Patients with mild acute asthma attack who did not respond to nebulized salbutamol treatment at 3 doses (0.15 mg/ kg/dose) administered within the first hour, were included in the study. The patients were randomly divided into two groups. Group A received single-dose systemic steroid (1mg/kg) while Group B received single-dose nebulized budesonide (500μg). The groups were compared in terms of demographics, % O2 saturation, pulmonary index score (PIS), and duration of hospital stay. Results: A total of 61 cases were enrolled to the study (Group A n=33, Group B n=28). There was no statistically significant difference between groups in terms of mean age and gender (P>0.05). In both groups, % O2 saturation values at 4th hour of treatment increased and PIS regressed significantly compared to the baseline values (P0.05). Conclusion: Based on the results of our study, a single dose (500μg) of nebulized budesonide was shown to be as effective as systemic steroid therapy in the treatment of mild acute asthma attacks.

PDF

___

1. Van den Akker-Van Marle ME, Bruil J, Detmar SB. Evaluation of cost of disease: assessing the burden to society of asthma in children in the European Union. Allergy 2005;60:140-9.
2. 2006 GINA report, Global strategy for astma management and prevention. https://ginasthma.org/ gina-reports
3. Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R, et al. International consensus on (ICON) pediatric asthma. Allergy 2012;67:976-97.
4. Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34.
5. Scarfone RJ, Loiselle JM, Wiley JF 2nd, Decker JM, Henretig FM, Joffe MD. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann Emerg Med 1995;26:480-6.
6. Milani GK, Rosário Filho NA, Riedi CA, Figueiredo BC. Nebulized budesonide to treat acute asthma in children. J Pediatr (Rio J) 2004;80:106-12.
7. Devidayal, Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999;88:835- 40.
8. Arulparithi CS, Babu TA, Ravichandran C, Santhanam I, Sathyamurthi B, Parivathini S, et al. Efficacy of nebulised budesonide versus oral prednisolone in acute severe asthma. Indian J Pediatr 2015;82:328- 32.
9. Sharma S, Harish R, Dutt N, Digra KK. To evaluate the efficacy of nebulized budesonide compared to oral prednisolone in the management of moderate exacerbation of acute asthma. Int J Contemp Pediatr 2017;4:1278-83.
10. Matthews EE, Curtis PD, McLain BI, Morris LS, Turbitt ML. Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma. Acta Paediatr 1999;88:841-3.
11. Kaya Z, Turktas I. Efficacy of Nebulized Budesonide Compared to Oral Prednisolone in Acute Bronchial Asthma Treatment. Turkiye Klinikleri J Allergy-Asthma 2003;5:25-9.
12. Volovitz B, Bentur L, Finkelstein Y, et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998;102:605-9.
13. Sekerel BE, Sackesen C, Tuncer A, et al. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta Paediatr 2005;94:1372-7.
14. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000;343:689- 94.
15. Schuh S, Dick PT, Stephens D, et al. High dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics 2006;118:644-50.
16. Macias CG, Felner EI, Gan V. Inhaled corticosteroids may be superior to systemic corticosteroids in children with moderate-to-severe acute asthma. Pediatr Asthma Allergy Immunol 2003;16:121-8.
17. Chen A, Zeng G, Chen R, et al. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology 2013;18:47-52.
18. Tsai YG, Lee MY, Yang KD, et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr 2001;139:433- 7.
19. Singhi S, Banerjee S, Nanjundaswamy H. Inhaled budesonide in acute asthma. J Paediatr Child Health 1999;35:483-7.
20. Alangari AA, Malhis N, Mubasher M, et al. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children. Chest 2014;145:772-8.
21. Nuhoglu Y, Atas E, Nuhoglu C, et al. Acute effect of nebulized budesonide in asthmatic children. J Investig Allergol Clin Immunol 2005;15:197-200
22. Razi CH, Cörüt N, Andiran N. Budesonide reduces hospital admission rates in preschool children with acute wheezing. Pediatr Pulmonol 2017;52:720-8.
23. 2020 GINA report, Global strategy for astma management and prevention. https://ginasthma.org/ gina-reports.
24. Beker AB, Nelson NA, Simons FE. The pulmonary index: Assessment of a clinical score for asthma. Am J Dis Child 1984;138:574-6.
25. Kearns N, Maijers I, Harper J, Beasley R, Weatherall M. Inhaled Corticosteroids in Acute Asthma: A Systemic Review and Meta-Analysis. J Allergy Clin Immunol Pract 2020;8:605-17.